Navigation Links
The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future
Date:7/31/2008

Three-Months Three-Months Six-Months Six-Months

Ended Ended Ended Ended

June 30, June 30, June 30, June 30,

2008 2007 2008 2007

($) ($) ($) ($)

Net Sales 2,068 2,217 7,373 8,367

Gross profit 898 995 4,467 4,934

Sales & marketing expenses 566 556 2,799 3,046

Administrative expenses 2,030 2,436 4,538 4,582

Research & development 1,265 1,622 2,675 2,774

Income taxes (benefit) - - - -

Income (Loss) from:

Continuing operations (2,879) (3,417) (5,324) (5,058)

Discontinued operations - (103) 876 (390)

Net Income (Loss) (2,879) (3,520) (4,448) (5,448)

Diluted income (loss)

per share:

Continuing operations ($0.22) ($0.27) ($0.42) ($0.40)

Discontinued operations - (0.01) 0.07 (0.03)

Net loss ($0.22) ($0.28) ($0.35) ($0.43)

Diluted weighted average

common shares

outstanding: 12,861,800 12,684,633 12,860,616 12,684,633

Consolidated Balance Sheets (Unaudited)

The following represents condensed financial data (in thousands) at June 30, 2008 and December 31, 2007:

2008 2007

($) ($)

Cash & cash equivalents 14,375 15,134

Accounts receivable, net 1,613 6,649

Inventory
'/>"/>

SOURCE Quigley Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
2. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
3. Roche and Response Biomedical Corporation Aim to Reduce Vein-to-Brain Time with New Point-of-Care Cardiac Tests
4. CorVel Corporation Announces Earnings Release Webcast
5. Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases
6. Webcast Alert: Neogen Corporation Announces Year-End Results
7. PURE Bioscience Announces Distribution Agreement With Orchem Corporation
8. Sigma-Aldrich Corporations 2nd Quarter 2008 Earnings Conference Call
9. Genaera Corporation Elects Paul K. Wotton to Board of Directors
10. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
11. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...onal carbon layer in which the carbon atoms are ar...omb. Carbon nanotubes are rolled-up sheets of grap...hite. Graphene boasts some very special characteri...t thermal conductor, and reconciles such conflicti...tion, graphene is impermeable to gases, which make...
(Date:11/23/2009)...wire-FirstCall/-YMBioSciencesInc.(NYSEAmex: YMI ;T...dentifiesandadvancesadiverseportfolioofpromisingca...odayreportedthatCytopia(ASX:CYT)hascommencedenroll...ly-administeredJAK1/JAK2inhibitor.Thetrialisbeingc...ltomergeCytopiaintoYMhasbeenpreviouslyannouncedand...
(Date:11/23/2009)...uo;s Sporicidin disinfectant solution and wipes ar...nts against H1N1 and Influenza A., , ...009 -- Contec Inc, the leading manufacturer of cl...icidin disinfectants have been deemed by the EPA ...uding Pandemic 2009 H1N1 influenza A virus (the sw...
(Date:11/23/2009).../-InimexPharmaceuticals,Inc.announcedtodaythatitha.... ,, Abramsbringsmorethan25yearsofdrugdiscovery...fthenuclearmedicineimagingagent,Cardiolite,andwork...ger,BiomedicalResearchWorldwide.In1996,Abramsledth...andCEOfrom1996to2006.AnorMEDdiscoveredanddeveloped...
Breaking Biology Technology:Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2
...OKYO, Japan, April 28 HOYA Corporation today,anno...n for the period,ended March 31, 2008, a 36.5% inc...rating income for the quarter was 18.0 billion yen...in the prior year period. Net,income for the fourt...are,were 37.71 yen. For the same quarter of the pr...
... Vaccine for new strain of virus broadens governme... France, April 28 ,Sanofi Pasteur, the vaccines di...at the U.S. Department of Health and Human Service...produce approximately 38.5 million,doses of vaccin...za. Sanofi,Pasteur has a multi- year contract with...
...ANJING, CHINA, April 28 Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals and manufa... Endu in China, today announced that it has been,i... Good Management,Limited, a British Virgin Islands...luding certain senior management of Simcere Pharma...
Other Biology Technology:Hoya Announces Fourth Quarter and FY2007 Financial Results 2Hoya Announces Fourth Quarter and FY2007 Financial Results 3U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 2U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 3U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 4Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 2Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 3
(Date:11/23/2009)...controvertible evidence" that the volcanic super-e...000 years ago deforested much of central India, so...ort. , The volcano ejected an estimated 800 cubi... crater (now the world,s largest volcanic lake) th...Ash from the event has been found in India, the In...
(Date:11/23/2009)...sity of Alabama at Birmingham (UAB) researchers sh...ical conditions (co-morbidity) do not explain the ...s compared to Caucasians who also have colon cance...r , a journal of the American Cancer Society. , ...bidity are independent predictors of poor survival...
(Date:11/23/2009)...ries about the multiple health benefits of vitamin...ient, increased awareness of the huge numbers of p...d even led to an appreciation of it as "nature,s a...of your immune system to prevention of heart disea...is now seen as one of the most critical nutrients ...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Par Pharmaceutical Receives Final Approval To Market Generic Starlix 28R 29 56816 1Par Pharmaceutical Receives Final Approval To Market Generic Starlix 28R 29 56816 2SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 1SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 2SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 3FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL 13986 1FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL 13986 2
...al Center have identified a previously unknown fam...esponsible for the plague especially efficient at ...nly demonstrated that the use of the common roundw... Yersinia pestis, the bacterium that causes plague... pestis and the worm is quite similar to what occu...
...ege are using tobacco plants to produce monoclonal...t can target and hunt down cancer cells. The plant...roducing anticancer antibodies, raising hopes that...cientists, led by Hilary Koprowski, M.D., professo...he Biotechnology Foundation Laboratories and the C...
...have made significant new advances in determining ...covery that in one sense takes up where Watson and...e-helical structure of this biological blueprint f...hemistry is to predict the structure of a molecule...he "Holy Grail" of protein chemistry. , Today, th...
Other Biology News:Novel plague virulence factor identified 2Novel plague virulence factor identified 3Novel plague virulence factor identified 4Scientists turn tobacco against cancer 2Major advance made on DNA structure 2Major advance made on DNA structure 3
21-mer duplex from B-Bridge International
...s the first fully genetically encoded fluorescent ...acellular hydrogen peroxide (H2O2), one of the mai...f yellow fluorescent protein inserted into the reg...xyR-RD), HyPer demonstrates submicromolar affinity...
Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: